Jingjing Miao
YOU?
Author Swipe
View article: Treatment response-adapted risk index model for survival prediction and adjuvant chemotherapy selection in nonmetastatic nasopharyngeal carcinoma
Treatment response-adapted risk index model for survival prediction and adjuvant chemotherapy selection in nonmetastatic nasopharyngeal carcinoma Open
Dynamic response to therapy is strongly associated with cancer outcomes. We aim to develop the response-adapted individualized risk index (RAIRI) as an individual prognostic approach and predictive biomarker for adjuvant chemotherapy (AC) …
View article: A multi-data fusion deep learning model for prognostic prediction in upper tract urothelial carcinoma
A multi-data fusion deep learning model for prognostic prediction in upper tract urothelial carcinoma Open
Background Upper tract urothelial carcinoma (UTUC) is a rare but highly invasive urinary malignancy with a high postoperative recurrence rate. Methods We retrospectively collected data from 133 UTUC patients who underwent radical nephroure…
View article: CACA guidelines for holistic integrative management of adolescent and childhood nasopharyngeal carcinoma
CACA guidelines for holistic integrative management of adolescent and childhood nasopharyngeal carcinoma Open
Adolescent and childhood nasopharyngeal carcinoma (NPC) is a rare malignancy with unique biological and genetic characteristics, often associated with Epstein-Barr virus (EBV). This CACA guideline provides an integrative approach to the ma…
View article: Deep learning-based multi-omics model to predict nasopharyngeal necrosis of re-irradiation for recurrent nasopharyngeal carcinoma
Deep learning-based multi-omics model to predict nasopharyngeal necrosis of re-irradiation for recurrent nasopharyngeal carcinoma Open
Background and purpose Patients with recurrent nasopharyngeal carcinoma (rNPC) undergoing re-irradiation have a high risk of lethal nasopharyngeal necrosis (NN), which may lead to massive nasopharyngeal hemorrhage or death. Predicting NN i…
View article: Development and validation of machine learning models for distant metastasis of primary hepatic carcinoma: a population-based study
Development and validation of machine learning models for distant metastasis of primary hepatic carcinoma: a population-based study Open
View article: CT based Intratumor and Peritumoral Features for Predicting Prognosis of Patients with Head and Neck Cancer after Chemoradiotherapy: Using a Features Fusion Model
CT based Intratumor and Peritumoral Features for Predicting Prognosis of Patients with Head and Neck Cancer after Chemoradiotherapy: Using a Features Fusion Model Open
Objective This study developed a fusion feature model integrating traditional radiomic (Rad) and deep-learning (DL) features from distinct peritumoral areas to predict outcomes in head and neck squamous cell carcinoma (HNSCC) patients afte…
View article: Ulinastatin in the treatment of radiotherapy-induced oral mucositis in locoregionally advanced nasopharyngeal carcinoma: a phase 3 randomized clinical trial
Ulinastatin in the treatment of radiotherapy-induced oral mucositis in locoregionally advanced nasopharyngeal carcinoma: a phase 3 randomized clinical trial Open
Radiotherapy-induced oral mucositis (RTOM) is a common side effect of radiotherapy in locoregionally advanced nasopharyngeal carcinoma (LA-NPC) receiving concurrent chemoradiotherapy (CCRT). In this phase 3 trial, we aim to evaluate the ef…
View article: Metabolic expression profiling analysis reveals pyruvate-mediated EPHB2 upregulation promotes lymphatic metastasis in head and neck squamous cell carcinomas
Metabolic expression profiling analysis reveals pyruvate-mediated EPHB2 upregulation promotes lymphatic metastasis in head and neck squamous cell carcinomas Open
Lymphatic metastasis is a well-known factor for initiating distant metastasis of head and neck squamous cell carcinoma (HNSCC), which caused major death in most patients with cancer. Meanwhile, metabolic reprogramming to support metastasis…
View article: Development of an Interpretable Machine Learning-Based Prediction Model for Long-Term Dysphagia Following Intensity-Modulated Radiotherapy in Nasopharyngeal Carcinoma
Development of an Interpretable Machine Learning-Based Prediction Model for Long-Term Dysphagia Following Intensity-Modulated Radiotherapy in Nasopharyngeal Carcinoma Open
View article: Metabolic expression profiling analysis reveals pyruvate-mediated EPHB2 upregulation promotes lymphatic metastasis in head and neck squamous cell carcinomas
Metabolic expression profiling analysis reveals pyruvate-mediated EPHB2 upregulation promotes lymphatic metastasis in head and neck squamous cell carcinomas Open
Lymphatic metastasis is a well-known factor for head and neck squamous cell carcinoma (HNSCC) that initiates distant metastasis, which caused major death in most patients with cancer. Metabolic reprogramming to support metastasis is regard…
View article: Association between the serum albumin–creatinine ratio and 28-day intensive care unit mortality among patients with sepsis: a multicenter retrospective cohort study
Association between the serum albumin–creatinine ratio and 28-day intensive care unit mortality among patients with sepsis: a multicenter retrospective cohort study Open
Introduction Sepsis is a substantial global health challenge with a considerable disease burden. Despite advancements in sepsis research, the mortality rates associated with this condition remain high. The relationship between the serum al…
View article: Regulatory challenges in innovation and evaluation of extracorporeal membrane oxygenation: Database analysis and future perspectives
Regulatory challenges in innovation and evaluation of extracorporeal membrane oxygenation: Database analysis and future perspectives Open
View article: Risk Factors of Level Ib Lymph Node Metastasis and Clinical Outcome of its Selectively Prophylactic Irradiation in Nasopharyngeal Carcinoma: A Real-World Study
Risk Factors of Level Ib Lymph Node Metastasis and Clinical Outcome of its Selectively Prophylactic Irradiation in Nasopharyngeal Carcinoma: A Real-World Study Open
View article: Improved Survival Prediction for Headneck Squamous Cell Carcinoma Patients with Rad-Dl Fusion Model Combining Radiomics and Deep Transfer Learning Features
Improved Survival Prediction for Headneck Squamous Cell Carcinoma Patients with Rad-Dl Fusion Model Combining Radiomics and Deep Transfer Learning Features Open
View article: Longitudinal post-radiotherapy plasma Epstein-Barr virus DNA trends inform on optimal risk stratification in endemic nasopharyngeal carcinoma
Longitudinal post-radiotherapy plasma Epstein-Barr virus DNA trends inform on optimal risk stratification in endemic nasopharyngeal carcinoma Open
We identified 302 patients with EBV DNA measured at 0-2 weeks post-radiotherapy; of which, 110 (36.4 %) underwent a repeat test at 8-12 weeks post-treatment. Patients harboring a detectable EBV DNA at 0-2 weeks experienced an inferior DFS …
View article: The m6A reader IGF2BP3 preserves NOTCH3 mRNA stability to sustain Notch3 signaling and promote tumor metastasis in nasopharyngeal carcinoma
The m6A reader IGF2BP3 preserves NOTCH3 mRNA stability to sustain Notch3 signaling and promote tumor metastasis in nasopharyngeal carcinoma Open
Metastasis remains the major cause of treatment failure in patients with nasopharyngeal carcinoma (NPC), in which sustained activation of the Notch signaling plays a critical role. N6-Methyladenosine (m6A)-mediated post-transcriptional reg…
View article: 916P Reducing radiation-induced temporal lobe injury by changing tumor prescription dose in nasopharyngeal carcinoma
916P Reducing radiation-induced temporal lobe injury by changing tumor prescription dose in nasopharyngeal carcinoma Open
View article: Efficacy of concurrent chemoradiotherapy alone for loco-regionally advanced nasopharyngeal carcinoma: long-term follow-up analysis
Efficacy of concurrent chemoradiotherapy alone for loco-regionally advanced nasopharyngeal carcinoma: long-term follow-up analysis Open
View article: Supplementary Data from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
Supplementary Data from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer Open
Supplementary Data
View article: FigureS1 from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
FigureS1 from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer Open
FigureS1
View article: FigureS2 from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
FigureS2 from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer Open
FigureS2
View article: Supplementary Data from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
Supplementary Data from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer Open
Supplementary Data
View article: Supplementary Data from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
Supplementary Data from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer Open
Supplementary Data
View article: Data from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
Data from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer Open
Purpose:Previous studies suggest that a cumulative cisplatin dose of 200 mg/m2 might be adequate in the intensity-modulated radiation therapy (IMRT) era for locoregionally advanced nasopharyngeal carcinoma (LANPC). However, two …
View article: FigureS1 from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
FigureS1 from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer Open
FigureS1
View article: Data from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
Data from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer Open
Purpose:Previous studies suggest that a cumulative cisplatin dose of 200 mg/m2 might be adequate in the intensity-modulated radiation therapy (IMRT) era for locoregionally advanced nasopharyngeal carcinoma (LANPC). However, two …
View article: FigureS2 from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
FigureS2 from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer Open
FigureS2
View article: Supplementary Data from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
Supplementary Data from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer Open
Supplementary Data
View article: Effects of induction chemotherapy on nutrition status in locally advanced nasopharyngeal carcinoma: a multicentre prospective study
Effects of induction chemotherapy on nutrition status in locally advanced nasopharyngeal carcinoma: a multicentre prospective study Open
Background Induction chemotherapy (IC) and concurrent chemoradiotherapy (CCRT) is the standard of care for locoregionally advanced nasopharyngeal carcinoma (LA‐NPC). This intensive treatment regimen increases acute toxicities, which could …
View article: Supplementary Material for: Efficacy of therapeutic apheresis for cryoglobulinemic vasculitis patients with renal involvement: a systematic review
Supplementary Material for: Efficacy of therapeutic apheresis for cryoglobulinemic vasculitis patients with renal involvement: a systematic review Open
Introduction: Therapeutic apheresis (TA) is commonly used for cryoglobulinemic vasculitis (CV) patients, but its efficacy remains uncertain. This systematic review aimed to assess the efficacy of different TA modalities, such as plasma exc…